Identification of miRNAs and associated pathways regulated by Leukemia Inhibitory Factor in trophoblastic cell lines.


Journal

Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349

Informations de publication

Date de publication:
12 2019
Historique:
received: 26 02 2018
revised: 06 08 2019
accepted: 10 09 2019
pubmed: 7 10 2019
medline: 25 8 2020
entrez: 7 10 2019
Statut: ppublish

Résumé

Leukemia Inhibitory Factor (LIF) regulates behavior of trophoblast cells and their interaction with immune and endothelial cells. In vitro, trophoblast cell response to LIF may vary depending on the cell model. Reported differences in the miRNA profile of trophoblastic cells may be responsible for these observations. Therefore, miRNA expression was investigated in four trophoblastic cell lines under LIF stimulation followed by in silico analysis of altered miRNAs and their associated pathways. Low density TaqMan miRNA assays were used to quantify levels of 762 mature miRNAs under LIF stimulation in three choriocarcinoma-derived (JEG-3, ACH-3P and AC1-M59) and a trophoblast immortalized (HTR-8/SVneo) cell lines. Expression of selected miRNAs was confirmed in primary trophoblast cells and cell lines by qPCR. Targets and associated pathways of the differentially expressed miRNAs were inferred from the miRTarBase followed by a KEGG Pathway Enrichment Analysis. HTR-8/SVneo and JEG-3 cells were transfected with miR-21-mimics and expression of miR-21 targets was assessed by qPCR. A similar number of miRNAs changed in each tested cell line upon LIF stimulation, however, low coincidence of individual miRNA species was observed and occurred more often among choriocarcinoma-derived cells (complete data set at http://www.ncbi.nlm.nih.gov/geo/ under GEO accession number GSE130489). Altered miRNAs were categorized into pathways involved in human diseases, cellular processes and signal transduction. Six cascades were identified as significantly enriched, including JAK/STAT and TGFB-SMAD. Upregulation of miR-21-3p was validated in all cell lines and primary cells and STAT3 was confirmed as its target. Dissimilar miRNA responses may be involved in differences of LIF effects on trophoblastic cell lines.

Identifiants

pubmed: 31586768
pii: S0143-4004(19)30663-0
doi: 10.1016/j.placenta.2019.09.005
pii:
doi:

Substances chimiques

LIF protein, human 0
Leukemia Inhibitory Factor 0
MIRN21 microRNA, human 0
MicroRNAs 0
STAT3 Transcription Factor 0
STAT3 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-27

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Diana M Morales-Prieto (DM)

Placenta-Labor, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.

Emanuel Barth (E)

Friedrich-Schiller-University Jena, Faculty of Mathematics and Computer Science, RNA Bioinformatics and High Throughput Analysis, Germany; Leibniz Institute for Age Research, Fritz Lipman Institute (FLI), Beutenbergstrasse 11, 07745, Jena, Germany.

Jose Martín Murrieta-Coxca (JM)

Placenta-Labor, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany; Departamento de Inmunología, Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Mexico City, Mexico.

Rodolfo R Favaro (RR)

Placenta-Labor, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.

Ruby N Gutiérrez-Samudio (RN)

Placenta-Labor, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.

Wittaya Chaiwangyen (W)

Placenta-Labor, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.

Stephanie Ospina-Prieto (S)

Placenta-Labor, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.

Bernd Gruhn (B)

Children's Hospital, Friedrich-Schiller University Jena, Kochstraße 2, 07745, Jena, Germany.

Ekkehard Schleußner (E)

Placenta-Labor, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.

Manja Marz (M)

Friedrich-Schiller-University Jena, Faculty of Mathematics and Computer Science, RNA Bioinformatics and High Throughput Analysis, Germany; Leibniz Institute for Age Research, Fritz Lipman Institute (FLI), Beutenbergstrasse 11, 07745, Jena, Germany; European Virus Bioinformatics Center, Leutragraben 1, 07743, Jena, Germany.

Udo R Markert (UR)

Placenta-Labor, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany. Electronic address: markert@med.uni-jena.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH